Product information

From Health Canada

Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.

Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.

Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.

New search

Natural Product Number (NPN):
Market status:
Licence Status:
Brand name(s):
Helixia Cough ;
Helixia Cough - Menthol Flavour ;
Prospan by Helixia
Licence holder:
PendoPharm, Division of/de Pharmascience Inc.
Dosage Form:
Recommended route of administration:


Recommended dose:
Sub population (Sub Pop.) Quantity (Qty) Frequency (Freq.)
Sub Pop. Age Min. Max. UoM Footnote1 Age Qty Min. Max. UoM Qty Freq. Min. Max. UoM Freq.
Adults and Adolescents 12 year(s) 5.0 mL 3 daily
Recommended use or purpose:
Used as an expectorant (helps mucus expulsion) to help relieve coughs. Helps to support/improve respiratory function in patients with chronic bronchitis. Helps to relieve coughs and helps expectoration (loosens mucus) in patients with chronic bronchitis. Used as an expectorant to help relieve symptoms associated with chronic bronchitis.
Risk Information:
Cautions and Warnings 
Do not use if you are allergic to ivy, sorbitol or to any of the other ingredients in Helixia Cough. If you are pregnant or breastfeeding, consult a healthcare practitioner before taking Helixia Cough. Do not exceed the recommended daily dose.
Known Adverse Reactions 
Dried Ivy Leaves may cause nausea, vomiting, diarrhoea and/or abdominal and epigastric pain in some people. Consult a healthcare professional if you have any side effects or if symptoms persist or worsen.
List of medicinal ingredients:
Medicinal ingredients Quantity (Qty) Extract Potency
Hedera helix 7.0 mg/ml
6.3 : 1
DHE: 43.75 mg
List of non-medicinal ingredients:
  • Citric acid
  • Flavour
  • Menthol
  • Potassium Sorbate
  • Purified water
  • Xanthan Gum
  • d-Sorbitol
Date of licensing:
Revised date of licence:

Application information

Related information

Compendium of monographs

Contact us

For technical support or if you have general questions concerning the content of this database, please contact the Natural Health Products Directorate (NHPD).

Date modified: